Daily magnesium supplementation effect on magnesium deficiency in rats during prolonged restriction of motor activity. 1998

Y G Zorbas, and Y Y Yaroshenko, and N K Kuznetsov, and G E Verentsov
Hypokinetic Physiology Laboratory, Odos Agias Sophias, Athens, Greece.

The objective of this investigation was to evaluate the effect of magnesium (Mg) supplements in rats during prolonged restriction of motor activity (hypokinesia [HK]) and in the presence of Mg deficiency, which is characterized by increased rather than decreased plasma Mg concentration, as occurs in ambulatory conditions. The studies were performed during 98 days of HK on 100 13-week-old Sprague-Dawlay male rats weighing 360 to 390 g. They were equally divided into four groups: (1) unsupplemented control animals (UCA), (2) unsupplemented hypokinetic animals (UHA), (3) supplemented control animals (SCA), and (4) supplemented hypokinetic animals (SHA). For the simulation of the hypokinetic effect, SHA and UHA were kept for 98 days in small individual wood cages that restricted their movements in all directions without hindering food and water intake. The SCA and SHA took daily with their food an additional 0.35 mg of Mg. Before and during the hypokinetic period of 98 days, Mg in plasma, urine, and feces, balance of Mg, food intake of Mg, and body weight were determined at different intervals. In SHA and UHA, plasma Mg concentration and excretion of Mg in urine and feces increased significantly compared with SCA and UCA. Magnesium balance was negative in UHA and AHA throughout the hypokinetic period. Body weight and a food intake decreased significantly in SHA and UHA when compared with SCA and UCA. Significant losses of Mg in SHA and UHA occurred in the presence of Mg deficiency and suggest that prolonged HK induces another factor that influences Mg metabolism. We conclude that prolonged HK causes significant changes in Mg values of plasma, urine, and feces and a negative Mg balance in rats, despite Mg supplements leading to Mg deficiency.

UI MeSH Term Description Entries
D007103 Immobilization The restriction of the MOVEMENT of whole or part of the body by physical means (RESTRAINT, PHYSICAL) or chemically by ANALGESIA, or the use of TRANQUILIZING AGENTS or NEUROMUSCULAR NONDEPOLARIZING AGENTS. It includes experimental protocols used to evaluate the physiologic effects of immobility. Hypokinesia, Experimental,Experimental Hypokinesia,Experimental Hypokinesias,Hypokinesias, Experimental
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D008275 Magnesium Deficiency A nutritional condition produced by a deficiency of magnesium in the diet, characterized by anorexia, nausea, vomiting, lethargy, and weakness. Symptoms are paresthesias, muscle cramps, irritability, decreased attention span, and mental confusion, possibly requiring months to appear. Deficiency of body magnesium can exist even when serum values are normal. In addition, magnesium deficiency may be organ-selective, since certain tissues become deficient before others. (Harrison's Principles of Internal Medicine, 12th ed, p1936) Deficiency, Magnesium,Deficiencies, Magnesium,Magnesium Deficiencies
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Y G Zorbas, and Y Y Yaroshenko, and N K Kuznetsov, and G E Verentsov
January 1999, Kidney & blood pressure research,
Y G Zorbas, and Y Y Yaroshenko, and N K Kuznetsov, and G E Verentsov
November 2000, Acta astronautica,
Y G Zorbas, and Y Y Yaroshenko, and N K Kuznetsov, and G E Verentsov
January 1993, Materia medica Polona. Polish journal of medicine and pharmacy,
Y G Zorbas, and Y Y Yaroshenko, and N K Kuznetsov, and G E Verentsov
January 1999, International urology and nephrology,
Y G Zorbas, and Y Y Yaroshenko, and N K Kuznetsov, and G E Verentsov
December 1995, Panminerva medica,
Y G Zorbas, and Y Y Yaroshenko, and N K Kuznetsov, and G E Verentsov
January 1998, Physiological chemistry and physics and medical NMR,
Y G Zorbas, and Y Y Yaroshenko, and N K Kuznetsov, and G E Verentsov
July 2022, European journal of applied physiology,
Y G Zorbas, and Y Y Yaroshenko, and N K Kuznetsov, and G E Verentsov
March 1998, Journal of physiology and biochemistry,
Y G Zorbas, and Y Y Yaroshenko, and N K Kuznetsov, and G E Verentsov
October 1995, Biological trace element research,
Y G Zorbas, and Y Y Yaroshenko, and N K Kuznetsov, and G E Verentsov
March 1994, Revista espanola de fisiologia,
Copied contents to your clipboard!